title: How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy.
authors.affiliation: Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Perelman School of Medicine of the University of Pennsylvania, Philadelphia.
authors.forename: Michael D
authors.initials: MD
authors.lastname: Farwell
authors.affiliation: Department of Medicine, Division of Hematology/Oncology, Perelman School of Medicine of the University of Pennsylvania, Philadelphia.
authors.forename: Amy S
authors.initials: AS
authors.lastname: Clark
authors.affiliation: Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Perelman School of Medicine of the University of Pennsylvania, Philadelphia.
authors.forename: David A
authors.initials: DA
authors.lastname: Mankoff
mesh_terms: D014408:Biomarkers, Tumor / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism; D002986:Clinical Trials as Topic / Q000379:methods*; D003661:Decision Support Techniques; D003952:Diagnostic Imaging / Q000379:methods*; D006801:Humans; D058990:Molecular Targeted Therapy; D009369:Neoplasms / Q000175:diagnosis* / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D018579:Patient Selection; D057285:Precision Medicine; D011237:Predictive Value of Tests; D012107:Research Design
chemical_list: D014408:Biomarkers, Tumor